Tokyo Tape
Sign in
← Sumitomo Chemical

Quarterly report · Q1

4005.TEDINET S100OVSY
Period2022-04-01 → 2022-06-30
Filed2022-08-05
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 45
MetricValuePeriodScopeSource row
Revenue¥774.1bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Revenue¥2.77T2021-04-01 → 2022-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥639.0bn2021-04-01 → 2021-06-30Cons.Revenue IFRS
Operating income¥66.3bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Operating income¥58.3bn2021-04-01 → 2021-06-30Cons.Operating profit loss IFRS
Profit before tax¥113.7bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Profit before tax¥251.1bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥56.7bn2021-04-01 → 2021-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥70.0bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥162.1bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥35.7bn2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥85.1bn2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Net income¥186.4bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥38.9bn2021-04-01 → 2021-06-30Cons.Profit loss IFRS
Total assets¥4.67Tat 2022-06-30Cons.Assets IFRS
Total assets¥4.31Tat 2022-03-31Cons.Assets IFRS
Total assets¥4.09Tat 2021-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥2.81Tat 2022-06-30Cons.Liabilities IFRS
Total liabilities¥2.61Tat 2022-03-31Cons.Liabilities IFRS
Net assets / equity¥1.86Tat 2022-06-30Cons.Equity IFRS
Net assets / equity¥1.70Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥1.50Tat 2021-06-30Cons.Equity IFRS
Net assets / equity¥1.48Tat 2021-03-31dCons.Equity IFRS
Equity (owners)¥1.34Tat 2022-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.22Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.05Tat 2021-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥498.6bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥365.4bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥366.5bnat 2021-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥360.9bnat 2021-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥42.6bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥171.7bn2021-04-01 → 2022-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥4.7bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow¥46.0bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥115.4bn2021-04-01 → 2022-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥41.3bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥11.5bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥81.4bn2021-04-01 → 2022-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥41.5bn2021-04-01 → 2021-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥42.812022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥99.162021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥21.812021-04-01 → 2021-06-30Cons.Basic earnings loss per share IFRS
Equity ratio28.8%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio28.3%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio25.5%at 2021-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥31.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥14.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥17.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30¥3.3bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥24.8bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥24.8bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥7.5bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentrevenue2022-04-01 → 2022-06-30¥91.3bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentrevenue external2022-04-01 → 2022-06-30¥86.4bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥4.8bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentsegment profit2022-04-01 → 2022-06-30¥6.6bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue2022-04-01 → 2022-06-30¥240.0bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue external2022-04-01 → 2022-06-30¥238.6bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥1.5bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentsegment profit2022-04-01 → 2022-06-30¥10.0bn
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentrevenue2022-04-01 → 2022-06-30¥153.5bn
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentrevenue external2022-04-01 → 2022-06-30¥152.6bn
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥945m
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentsegment profit2022-04-01 → 2022-06-30¥21.9bn
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentrevenue2022-04-01 → 2022-06-30¥114.8bn
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentrevenue external2022-04-01 → 2022-06-30¥114.7bn
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥116m
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentsegment profit2022-04-01 → 2022-06-30¥15.8bn
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentrevenue2022-04-01 → 2022-06-30¥167.7bn
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentrevenue external2022-04-01 → 2022-06-30¥167.7bn
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥6m
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentsegment profit2022-04-01 → 2022-06-30¥14.1bn
—segment totalrevenue2022-04-01 → 2022-06-30¥767.3bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥759.9bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥7.4bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥68.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-06-30¥27.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-06-30¥13.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-06-30¥14.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-06-30¥2.7bn
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥21.0bn
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥21.0bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥5.0bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentrevenue2021-04-01 → 2021-06-30¥77.4bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentrevenue external2021-04-01 → 2021-06-30¥74.4bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥3.0bn
jpcrp040300-q1r_E00752-000Energy And Functional Materialsreportable segmentsegment profit2021-04-01 → 2021-06-30¥6.7bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue2021-04-01 → 2021-06-30¥200.8bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue external2021-04-01 → 2021-06-30¥199.5bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥1.2bn
jpcrp040300-q1r_E00752-000Essential Chemicals And Plasticsreportable segmentsegment profit2021-04-01 → 2021-06-30¥23.8bn
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentrevenue2021-04-01 → 2021-06-30¥105.4bn
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentrevenue external2021-04-01 → 2021-06-30¥103.1bn
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥2.4bn
jpcrp040300-q1r_E00752-000Health And Agriculture Relatedreportable segmentsegment profit2021-04-01 → 2021-06-30¥10.3bn
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentrevenue2021-04-01 → 2021-06-30¥109.4bn
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentrevenue external2021-04-01 → 2021-06-30¥109.3bn
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥110m
jpcrp040300-q1r_E00752-000Information Electronic Chemistryreportable segmentsegment profit2021-04-01 → 2021-06-30¥13.5bn
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentrevenue2021-04-01 → 2021-06-30¥139.2bn
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentrevenue external2021-04-01 → 2021-06-30¥139.2bn
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥2m
jpcrp040300-q1r_E00752-000Medical Productsreportable segmentsegment profit2021-04-01 → 2021-06-30¥9.6bn
—segment totalrevenue2021-04-01 → 2021-06-30¥632.1bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥625.4bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥6.7bn
—segment totalsegment profit2021-04-01 → 2021-06-30¥63.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 785
ItemContextValueUnit
Revenue from external customers IFRSCurrentYTDDuration_jpcrp040300-q1r_E00752-000MedicalProductsReportableSegmentMember167728000000JPY
Revenue from external customers IFRSCurrentYTDDuration_ReportableSegmentsMember759923000000JPY
Revenue from external customers IFRSCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember14211000000JPY
Revenue from external customers IFRSCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenue from external customers IFRSCurrentYTDDuration774134000000JPY
Intersegment revenue IFRSCurrentYTDDuration_jpcrp040300-q1r_E00752-000EssentialChemicalsAndPlasticsReportableSegmentMember1465000000JPY
Intersegment revenue IFRSCurrentYTDDuration_jpcrp040300-q1r_E00752-000EnergyAndFunctionalMaterialsReportableSegmentMember4838000000JPY
Intersegment revenue IFRSCurrentYTDDuration_jpcrp040300-q1r_E00752-000InformationElectronicChemistryReportableSegmentMember116000000JPY
Intersegment revenue IFRSCurrentYTDDuration_jpcrp040300-q1r_E00752-000HealthAndAgricultureRelatedReportableSegmentMember945000000JPY
Intersegment revenue IFRSCurrentYTDDuration_jpcrp040300-q1r_E00752-000MedicalProductsReportableSegmentMember6000000JPY
Intersegment revenue IFRSCurrentYTDDuration_ReportableSegmentsMember7370000000JPY
Intersegment revenue IFRSCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember17457000000JPY
Intersegment revenue IFRSCurrentYTDDuration_ReconcilingItemsMember-24827000000JPY
Intersegment revenue IFRSCurrentYTDDuration－JPY
Revenue IFRSCurrentYTDDuration_jpcrp040300-q1r_E00752-000EssentialChemicalsAndPlasticsReportableSegmentMember240027000000JPY
Revenue IFRSCurrentYTDDuration_jpcrp040300-q1r_E00752-000EnergyAndFunctionalMaterialsReportableSegmentMember91265000000JPY
Revenue IFRSCurrentYTDDuration_jpcrp040300-q1r_E00752-000InformationElectronicChemistryReportableSegmentMember114766000000JPY
Revenue IFRSCurrentYTDDuration_jpcrp040300-q1r_E00752-000HealthAndAgricultureRelatedReportableSegmentMember153501000000JPY
Revenue IFRSCurrentYTDDuration_jpcrp040300-q1r_E00752-000MedicalProductsReportableSegmentMember167734000000JPY
Revenue IFRSCurrentYTDDuration_ReportableSegmentsMember767293000000JPY
Revenue IFRSCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember31668000000JPY
Revenue IFRSCurrentYTDDuration_ReconcilingItemsMember-24827000000JPY
Revenue IFRSCurrentYTDDuration774134000000JPY
Segment profit loss IFRSCurrentYTDDuration_jpcrp040300-q1r_E00752-000EssentialChemicalsAndPlasticsReportableSegmentMember9987000000JPY
Segment profit loss IFRSCurrentYTDDuration_jpcrp040300-q1r_E00752-000EnergyAndFunctionalMaterialsReportableSegmentMember6624000000JPY
Segment profit loss IFRSCurrentYTDDuration_jpcrp040300-q1r_E00752-000InformationElectronicChemistryReportableSegmentMember15770000000JPY
Segment profit loss IFRSCurrentYTDDuration_jpcrp040300-q1r_E00752-000HealthAndAgricultureRelatedReportableSegmentMember21905000000JPY
Segment profit loss IFRSCurrentYTDDuration_jpcrp040300-q1r_E00752-000MedicalProductsReportableSegmentMember14076000000JPY
Segment profit loss IFRSCurrentYTDDuration_ReportableSegmentsMember68362000000JPY
Segment profit loss IFRSCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember3275000000JPY
Segment profit loss IFRSCurrentYTDDuration_ReconcilingItemsMember-7526000000JPY
Segment profit loss IFRSCurrentYTDDuration64111000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2022-08-05
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第142期第１四半期(自　2022年４月１日　至　2022年６月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)住友化学株式会社
Company name in english cover pageFilingDateInstantSUMITOMO CHEMICAL COMPANY, LIMITED
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　岩　田　圭　一
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都中央区日本橋二丁目７番１号
Telephone number address of registered headquarter cover pageFilingDateInstant03(5201)0235
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)執行役員　経理部長　　山　内　利　博
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都中央区日本橋二丁目７番１号
Telephone number nearest place of contact cover pageFilingDateInstant03(5201)0235
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)執行役員　経理部長　　山　内　利　博
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE00752
Fund codeFilingDateInstant－
Security codeFilingDateInstant40050

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass